Litcius/Paper detail

Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?

Cem Akin, Michel Arock, Peter Valent

2022Journal of Allergy and Clinical Immunology47 citationsDOI

Topics & Concepts

Systemic mastocytosisTyrosine kinaseTyrosine-kinase inhibitorTyrosineMedicineCancer researchInternal medicineChemistryBiochemistryReceptorCancerDiseaseMast cells and histamineUrticaria and Related ConditionsAutoimmune Bullous Skin Diseases
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet? | Litcius